Literature DB >> 13022874

Antituberculous immunity induced in mice by vaccination with living cultures of attenuated tubercle bacilli.

R J DUBOS, C H PIERCE, W B SCHAEFER.   

Abstract

The immunity induced in mice by vaccination with living attenuated cultures of tubercle bacilli was measured by two criteria. (a) Increase in survival time of the vaccinated animals after infection with a dose of virulent bacilli sufficient to kill all the unvaccinated controls within 10 to 20 days. (b) Difference in the number of living bacilli recovered from the spleen and lungs of vaccinated and normal animals infected with a small dose of virulent bacilli. The level of immunity induced was found to depend upon the extent of multiplication in vivo of the bacilli used for vaccination. This in turn was conditioned by the degree of attenuation characteristic of the bacterial strain used in the preparation of the vaccine, the amount of vaccine injected, the route of vaccination, and the time interval between vaccination and challenge infection. It was possible to prevent or retard the development of immunity by treating the mice in course of immunization with a drug, isoniazid, capable of interrupting the multiplication in vivo of the bacilli used as vaccine. Although immunity regularly developed and lasted for many weeks when the proper conditions of vaccination were used, the immune response was never sufficient to protect the animals against ultimate death from infection with virulent tubercle bacilli. The prolongation of life in the vaccinated mice was not consequent on a direct bactericidal effect but rather on a retarded or interrupted multiplication of the virulent bacilli in vivo. The quantitative bacteriological techniques used in the present study would appear to be of value for the analysis of certain problems of immunity, and for the appraisal of vaccines and techniques of vaccination.

Entities:  

Keywords:  TUBERCULOSIS/immunology

Mesh:

Year:  1953        PMID: 13022874      PMCID: PMC2136191          DOI: 10.1084/jem.97.2.207

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  Effect of BCG vaccination and chemotherapy on experimental tuberculosis in mice.

Authors:  C O SIEBENMANN
Journal:  J Immunol       Date:  1951-08       Impact factor: 5.422

2.  Antituberculous immunity in mice vaccinated with killed tubercle bacilli.

Authors:  R J DUBOS; W B SCHAEFER; C H PIERCE
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

3.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

  3 in total
  21 in total

Review 1.  BCG OVERDOSAGE TREATED WITH ISONIAZID.

Authors:  A H GRIFFITH
Journal:  Postgrad Med J       Date:  1964-02       Impact factor: 2.401

2.  Resistance to reinfection in experimental mouse typhoid.

Authors:  D HOBSON
Journal:  J Hyg (Lond)       Date:  1957-09

3.  The immunizing activity against tuberculous infection in mice of enzymatically active particles isolated from extracts of Mycobacterium tuberculosis.

Authors:  G P YOUMANS; I MILLMAN; A S YOUMANS
Journal:  J Bacteriol       Date:  1955-11       Impact factor: 3.490

4.  Studies on tularemia. II. The antigenic properties of variants of Pasteurella tularensis in various hosts.

Authors:  C M DOWNS; M D MOODY
Journal:  J Bacteriol       Date:  1955-09       Impact factor: 3.490

5.  The protection of infants against tuberculosis.

Authors:  W GAISFORD
Journal:  Br Med J       Date:  1955-11-12

6.  A measurable tuberculous lesion in the thigh of the mouse.

Authors:  F R SELBIE; F O'GRADY
Journal:  Br J Exp Pathol       Date:  1954-12

7.  The host response to Calmette-Guérin bacillus infection in mice.

Authors:  R V Blanden; M J Lefford; G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

8.  Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses.

Authors:  F Romain; C Horn; P Pescher; A Namane; M Riviere; G Puzo; O Barzu; G Marchal
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

9.  Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals.

Authors:  E J Bardana; J K McClatchy; R S Farr; P Minden
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

10.  Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex.

Authors:  A Laqueyrerie; P Militzer; F Romain; K Eiglmeier; S Cole; G Marchal
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.